Dapagliflozin, a sodium–glucose cotransporter-2 (SGLT2) inhibitor, provides glycemic control and has proven cardiovascular and renal benefits in large trials, but its real-world use in Sudan has not been described. This study aimed to describe clinical characteristics, safety, adherence, and outcomes among Sudanese...
Manasik Nasreldeen, Toga K. Mohamed, Anas Babiker et al.· Scientific Reports· 0 citations
Background: Breast cancer remains the most common cancer among women worldwide and a major cause of preventable cancer mortality, particularly in resource-constrained settings where delayed presentation is common. Breast self-examination (BSE) does not replace clinical assessment or mammography, but breast self-awarene...
Malaz Saad Al-din Mohammed, Fatima Mohammed Osman, Ekram Al Ebeid Al Sayed et al.· Journal of Advances in Medic...· 0 citations
The findings revealed that over a half of the participants had antihypertensive related DTPs, and the most common DTP was dosage too low indicating a need for dosage management.
Ampereza Christine, Mohammed H. Alnazeer, Safa A. Abdalla et al.· Scientific Reports· 0 citations
A cost-effective computational workflow for prioritizing ENR inhibitors is demonstrated, providing a foundation for the development of novel antimalarial agents and highlighting Cd3 and Cd5 as the most promising candidates for further development.
Abozur Mohamed Mohyeldin Khalil, Carlos Eliel Maya-Ramírez, A. A. Razzak Mahmood et al.· In Silico Pharmacology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.